Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank 薬物名(臨床試験情報から抽出) KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acetate 1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
2 Clenbuterol 2件: Clenbuterol; CLENBUTEROL HYDROCHLORIDE2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 1, 2, 6, 57, 113, 256 💬
3 Creatine 3件: Acetic acid; Creatine; Creatine monohydrate---18件: 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
4 Dutasteride 2件: Dutasterida; DUTASTERIDE1件: Dutasteride 💬 2件: SRD5A1,
SRD5A2 💬
2件: Prostate cancer, Steroid hormone biosynthesis 💬2件: 1, 2 💬
5 Goserelin 1件: Goserelin2件: Goserelin acetate ,
Goserelin 💬
1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 1, 60 💬
6 Leuprolide 2件: Leuprolide; Leuprorelin3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬
1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬5件: 1, 2, 3, 51, 76 💬
7 Mexiletine 2件: Mexiletine; Mexiletine hydrochloride2件: Mexiletine hydrochloride ,
Mexiletine 💬
6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬6件: 1, 2, 10, 113, 114, 115 💬
8 Testosterone 1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬9件: 1, 2, 3, 13, 60, 76, 78, 113, 265 💬